Bibliography
- National Diabetes Clearinghouse. National Diabetes Statistics 2011. National Institute of Health, USA. Available from: http://diabetes.niddk.nih.gov/dm/pubs/statistics/#Diagnosed20
- Ferrer JC, Favre C, Gomis RR, Control of glycogen deposition. FEBS Lett 2003;546:127-32
- Henry RR, Ciaraldi TP, Abrams-Carter L, Glycogen synthase activity is reduced in cultured skeletal muscle cells of non-insulin-dependent diabetes mellitus subjects. Biochemical and Molecular Mechanisms. J Clin Invest 1996;98:1231-6
- Krssak M, Brehm A, Bernroider E, Alterations in postprandial hepatic glycogen metabolism in type 2 diabetes. Diabetes 2004;53:3048-56
- Virkamaki A, Yki-Jarvinen H. Allosteric regulation of glycogen synthase and hexokinase by glucosamine-6-phosphate during glucosamine-induced insulin resistance in skeletal muscle and heart. Diabetics 1999;48:1101-7
- F. Hoffman-La Roche AG. Biaryloxymethylarenecarboxylic acids as glycogen synthase activator. US0266856; 2004
- F. Hoffman-La Roche AG. Biaryloxymethylarenecarboxylic acids. WO06058648; 2006
- F. Hoffman-La Roche AG. Aniline analogs as glycogen synthase activators. US7939569; 2011
- F. Hoffman-La Roche AG. Benzisoxazole analogs as glycogen synthase activators. WO11057956; 2011
- F. Hoffman-La Roche AG. Indazolone derivatives as glycogen synthase activators. WO11057993; 2011
- F. Hoffman-La Roche AG. Biphenyl carboxylic acids and bioisosteres as glycogen synthase activators. WO11058154; 2011
- F. Hoffman-La Roche AG. Carboxylic acids analogs as glycogen synthase activators. WO11067266; 2011
- Skaltsounis A-L, Gaboriaud-Kolar N. Indole and indazole derivatives as glycogen synthase activators: a patent evaluation (WO2011057959). Exp Opin Ther Patents 2011;21:1925-9
- Uto Y. Piperidine and pyrrolidine analogs as glycogen synthase activators; a patent evaluation (WO2011058122). Exp Opin Ther Patents 2012;22:89-93
- Discovery of potent, selective and orally efficacious glycogen synthase activators as a potential treatment for type 2 diabetes. Medi-529. 239th American Chemical Society National Meeting and Exposition; San Francisco; 2010
- A Novel Approach for the Treatment of Type 2 Diabetes (T2D): Characterization of a Potent, Orally Active, Small Molecule Glycogen Synthase Activator. Abs 1389-P. 70th Annual Meeting and Scientific Sessions of the American Diabetes Association; Orlando; 2010
- Ferraris D, Duvall B, Ko YS, Synthesis and biological evaluation of D-amino acid oxidase inhibitors. J Med Chem 2008;51:3357-9
- Cole P, Vasiliou S, Rosa E, Fernandez-Forner D. Medicinal chemistry highlights from the 239th American Chemical Society National Meeting & Exposition. Drugs Future 2010;35:503